3,250 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 585 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,250
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
3076
$211K
3077
$211K
3078
$211K
3079
$210K
3080
$210K
3081
$210K
3082
$208K
3083
$208K
3084
$208K
3085
$208K
3086
$208K
3087
$208K
3088
$208K
3089
$207K
3090
$206K
3091
$206K
3092
$206K
3093
$206K
3094
$205K
3095
$204K
3096
$204K
3097
$203K
3098
$202K
3099
$202K
3100
$201K